<?xml version="1.0" encoding="UTF-8"?>
<p>Mosquito-borne Zika virus (ZIKV) is an emerging flavivirus initially reported in Africa in 1947 [
 <xref rid="B1-vaccines-07-00066" ref-type="bibr">1</xref>]. Recently, ZIKV became a public health concern with recent epidemics occurring in Yap islands (2007), French Polynesia (2013), and South America (2015) [
 <xref rid="B2-vaccines-07-00066" ref-type="bibr">2</xref>]. During these outbreaks, ZIKV infection was reported to cause severe complications in humans, such as developmental abnormalities in infants and Guillain-Barre syndrome in adults [
 <xref rid="B3-vaccines-07-00066" ref-type="bibr">3</xref>]. Also, ZIKV is capable of long-term persistence in human body fluids and sexual transmission of disease has been documented [
 <xref rid="B4-vaccines-07-00066" ref-type="bibr">4</xref>,
 <xref rid="B5-vaccines-07-00066" ref-type="bibr">5</xref>]. 
</p>
